reports
- Heidi Mo Jinghui
- John Cheong Ming Chern
Nanofilm Technologies International Ltd - 1H25: Revenue In Line But Ea...
Nanofilm’s 1H25 revenue of S$107m (+30% yoy) met our expectation, forming 46% of our full-year estimate. However, earnings remain soft, at only S$1.6m or 12% of our full-year estimate (vs S$3.7m loss in 1H24) due to a softer gross margin. Revenue growth was driven by the AMBU and IEBU segments. Nanofilm expects consistent growth in 2025. Although Nanofilm’s revenue is healthy, it may take time to achieve meaningful earnings. Maintain SELL with a 22% higher target price of S$0.56.
- Adrian Loh Tzum Yung
- Heidi Mo Jinghui
- John Cheong Ming Chern
- Jonathan Koh
- Lester Siew
- Roy Chen Chengzhi
Singapore Daily: Friday, August 15, 2025
KEY HIGHLIGHTS Results AEM Holdings (AEM SP/SELL/S$1.51/Target:S$1.25): 1H25: Revenue in line but earnings miss expectations; maintain SELL. CapitaLand Investment (CLI SP/BUY/S$2.72/Target: S$3.49): 1H25: Strategic recycling and lodging expansion support growth outlook. Maintain BUY. ComfortDelGro Corporation (CD SP/BUY/S$1.53/Target: S$1.70): 2Q25: A steady ride with decent yield and earnings growth. First Resources (FR SP/BUY/S$1.68//Target: S$1.85): 1H25: Results above expectations thank...
- Arnaud Riverain
Equasens: H1 revenue at 30 June 2025: €116.0m
Equasens: H1 revenue at 30 June 2025: €116.0m Villers-lès-Nancy (France), 31 July 2025 - 6:00 PM (CET) PRESS RELEASE H1 revenue at 30 June 2025: €116.0m+7.4% on a reported basis and +6.4% like-for-like H1 2025 Group revenue (€m)2024Reported basis2025Reported basisChange /Reported basisOf which external growthLike-for-like change(organic growth)Q153.357.03.76.9%0.53.25.9%Q254.758.94.37.8%0.53.86.9%Total108.0116.08.07.4%1.16.96.4%H1 2025 revenue / Division (€m)2024Reported basis2025Reported basisChange /Reported basisOf which external growthLike-for-like change(organic growthPharmagest82,1...
EQUASENS : Chiffre d’affaires au 30 juin 2025 à 116,0 M€
EQUASENS : Chiffre d’affaires au 30 juin 2025 à 116,0 M€ Villers-lès-Nancy, le 31 juillet 2025 - 18h00 (CET) COMMUNIQUE DE PRESSE Chiffre d’affaires au 30 juin 2025 à 116,0 M€+7,4% en croissance publiée et + 6,4% en croissance organique CA S1 2025 Groupe (M€)Publié 2024Publié 2025Variation /publiéDont Croissances externesVariation /périmètre comparable (croissance organique)T153,357,03,76,9%0,53,25,9%T254,758,94,37,8%0,53,86,9%Total108,0116,08,07,4%1,16,96,4%CA S1 2025 / Division (M€)Publié 2024Publié 2025Variation /publiéDont Croissances externesVariation /périmètre comparable (croissan...
- Anthony Dick
- Emira Sagaama
- Margaux van Oerle
- Michael Foundoukidis
- Usama Tariq
SOP SOPRA STERIA GROUP SA
VAC PIERRE & VACANCES SA
NXI NEXITY SA CLASS A
BIO BB BIOTECH AG
POM PLASTIC OMNIUM SE
MERY MERCIALYS SA
ASY ASSYSTEM SA
BEN BENETEAU SA
ALTR ALTRI SGPS SA
SWP SWORD GROUP SE
CGM CEGEDIM SA
FII LISI SA
LSS LECTRA SA
LNA LNA SANTE SA
GBT GUERBET SA
ATE ALTEN SA
ACX ACERINOX SA
FR VALEO SE
BAMNB KONINKLIJKE BAM GROEP NV
FAE FAES FARMA S.A.
COFB COFINIMMO SA
SUN SULZER AG
TUB TUBACEX S.A.
HEIJM HEIJMANS N.V. CERT
MBWS
CTAC MARIE BRIZARD WINE & SPIRITS SA
PAL CTAC N.V.
CON PALFINGER AG
LIGHT CONZZETA AG
NVG SIGNIFY NV
WBD NAVIGATOR COMPANY SA
RENE WEBUILD S.P.A.
ROVI REDES ENERGETICAS NACIONAIS SA
COL LABORATORIOS FARMACEUTICOS ROVI S.A.
ALM INMOBILIARIA COLONIAL SOCIMI SA
TEC ALMIRALL SA
HOME TECHNIPFMC PLC
VOS NEINOR HOMES SA
2CRSI VOSSLOH AG
VK 2CRSI SA
WDP VALLOUREC SA
ALHG WAREHOUSES DE PAUW SCA
LOUIS HACHETTE GROUP
- Anthony Dick
- Emira Sagaama
- Margaux van Oerle
- Michael Foundoukidis
- Usama Tariq
SOP SOPRA STERIA GROUP SA
VAC PIERRE & VACANCES SA
NXI NEXITY SA CLASS A
BIO BB BIOTECH AG
POM PLASTIC OMNIUM SE
MERY MERCIALYS SA
ASY ASSYSTEM SA
BEN BENETEAU SA
ALTR ALTRI SGPS SA
SWP SWORD GROUP SE
CGM CEGEDIM SA
FII LISI SA
LSS LECTRA SA
LNA LNA SANTE SA
GBT GUERBET SA
ATE ALTEN SA
ACX ACERINOX SA
FR VALEO SE
BAMNB KONINKLIJKE BAM GROEP NV
FAE FAES FARMA S.A.
COFB COFINIMMO SA
SUN SULZER AG
TUB TUBACEX S.A.
HEIJM HEIJMANS N.V. CERT
MBWS
CTAC MARIE BRIZARD WINE & SPIRITS SA
PAL CTAC N.V.
CON PALFINGER AG
LIGHT CONZZETA AG
NVG SIGNIFY NV
WBD NAVIGATOR COMPANY SA
RENE WEBUILD S.P.A.
ROVI REDES ENERGETICAS NACIONAIS SA
COL LABORATORIOS FARMACEUTICOS ROVI S.A.
ALM INMOBILIARIA COLONIAL SOCIMI SA
TEC ALMIRALL SA
HOME TECHNIPFMC PLC
VOS NEINOR HOMES SA
2CRSI VOSSLOH AG
VK 2CRSI SA
WDP VALLOUREC SA
ALHG WAREHOUSES DE PAUW SCA
LOUIS HACHETTE GROUP
- Christophe Chaput
- Christophe Chaput
NANOBIOTIX Announces Regulatory Harmonization and New Composition of M...
NANOBIOTIX Announces Regulatory Harmonization and New Composition of Matter Patent Filed for JNJ-1900 (NBTXR3) Health authorities in major European countries have accepted the reclassification of JNJ-1900 (NBTXR3) from a medical device to a medicinal product, aligning with regulatory status in the US and other major marketsMedicinal product classification supports unified global regulatory classification, facilitating future global strategies and filingsNew composition of matter patent for JNJ-1900 (NBTXR3) filed by Nanobitotix PARIS and CAMBRIDGE, Mass., July 07, 2025 (GLOBE NEWSWIRE) -...
NANOBIOTIX annonce une harmonisation réglementaire et le dépôt d’une d...
NANOBIOTIX annonce une harmonisation réglementaire et le dépôt d’une demande d’un nouveau brevet de composition de matière pour JNJ-1900 (NBTXR3) Les autorités de santé des principaux pays européens ont accepté la reclassification de JNJ-1900 (NBTXR3) en tant que médicament, au lieu de dispositif médical, alignant ainsi son statut réglementaire sur celui en vigueur aux États-Unis et dans d'autres marchés majeurs.Cette classification en tant que médicament permet une harmonisation réglementaire mondiale, facilitant les futures stratégies et dépôts réglementaires internationaux.Un nouveau bre...
Equasens: Appointment at the head of the Pharmagest Division
Equasens: Appointment at the head of the Pharmagest Division Villers-lès-Nancy (France), July 03, 2025 – 06 :00pm (CET) Press Release Equasens announces the departure of Damien VALICON, as Deputy Chief Executive Officer and Director of the Pharmagest Division He will be replaced by François-Pierre MARQUIER as Director of the Pharmagest Division. *** (Euronext Paris™ - Compartment B - FR 0012882389 –$EQS), announces the departure of Damien VALICON, who held the position of Deputy Chief Executive Officer and Director of the Pharmagest Division for 18 months, and the appointment of Fran...
EQUASENS : Nomination à la direction de la Division Pharmagest
EQUASENS : Nomination à la direction de la Division Pharmagest Villers-lès-Nancy, le 03 juillet 2025 - 18h00 (CET) COMMUNIQUE DE PRESSE Equasens annonce le départ de Damien VALICON, Directeur Général Délégué et Directeur de la Division PHARMAGEST Il sera remplacé par François-Pierre MARQUIER en tant que Directeur de la Division Pharmagest *** (Euronext Paris™ - Compartiment B - FR 0012882389 –$EQS), annonce le départ de Damien VALICON, qui occupait depuis 18 mois les fonctions de Directeur Général Délégué du Groupe et de Directeur de la Division PHARMAGEST, ainsi que la nomination de...
Equasens: General meeting - Results of the votes
Equasens: General meeting - Results of the votes Villers-lès-Nancy, 1st July 2025 – 07:00 p.m. (CET) PRESS RELEASE RESULTS OF THE VOTES ON THE RESOLUTIONS SUBMITTED TO THE ORDINARY ANNUAL SHAREHOLDERS' MEETING OF 25 JUNE 2025 Number of shares comprising the share capital: 15,174,125 Number of shares with voting rights: 14,830,415 Number of shares with voting rights possessed by shareholders presents or represented or having voted by mail: 13,173,125 That means a quorum of 88.83% of the 14,830,415 shares with voting rights: the Ordinary Annual General Meeting was able to deli...
EQUASENS : Assemblée Générale - Résultats des votes
EQUASENS : Assemblée Générale - Résultats des votes Villers-lès-Nancy, le 1er juillet 2025 – 19 :00 (CET) COMMUNIQUE DE PRESSE RESULTAT DU VOTE DES RESOLUTIONS PRESENTEES A L’ASSEMBLEE GENERALE ORDINAIRE ANNUELLE DU 25 JUIN 2025 Nombre d’actions composant le capital social : 15.174.125 Nombre d’actions ayant le droit de participer au vote : 14.830.415 Nombre d’actions, ayant droit de vote, possédées par les actionnaires présents ou représentés ou ayant voté par correspondance : 13.173.125 Soit un quorum de 88,83% des 14.830.415 actions ayant le droit de participer au vote : l...
- Arnaud Riverain
Equasens: acquisition of DIS and RESURGENCES BUSINESSES
Equasens: acquisition of DIS and RESURGENCES BUSINESSES Villers-lès-Nancy (France), 30 June 2025 - 06:00 PM (CET) PRESS RELEASE EQUASENS ACQUIRES DIS AND RESURGENCES BUSINESSES, STRENGTHENING ITS POSITION IN THE MARKET OF SOFTWARE SOLUTIONS FOR HEALTHCARE ESTABLISHMENTS. Strengthening the position of a leading provider of software solutions for hospitals and the medical-social sector Transaction finalised: acquisition of Novaprove, publisher of ResUrgences software and the DIS business assets, (GESDIS, FACDIS, ARCADIS ranges)Acquisition scope: more than 300 customers in th...
EQUASENS : ACQUISITION DES ACTIVITES DIS ET RESURGENCES
EQUASENS : ACQUISITION DES ACTIVITES DIS ET RESURGENCES Villers-lès-Nancy, le 30 juin 2025 - 18h00 (CET) COMMUNIQUE DE PRESSE EQUASENS ANNONCE L’ACQUISITION DES ACTIVITES DIS ET RESURGENCES ET RENFORCE AINSI SA POSITION SUR LE MARCHE DES LOGICIELS POUR LES ETABLISSEMENTS DE SANTE. Renforcement d'un acteur de référence dans les logiciels hospitaliers et médico-sociaux Opération finalisée : acquisition de la société Novaprove, éditeur du logiciel ResUrgences et du fonds de commerce de l'activité DIS (gamme GESDIS, FACDIS, ARCADIS)Périmètre consolidé : plus de 300 clients dans le secteur...
Nanobiotix: 1 director
A director at Nanobiotix bought 11,000 shares at 5.622USD and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...
- Jeremy Garnier
ODDO : ODDO BHF Nextcap Forum 2025: Feedback
Our 14th edition of the ODDO BHF Nextcap Forum took place on 11 June in Paris, and on 12 June virtually. 96 companies and 170 investors were present for more than 700 meetings organized. Overall, we noted a still cautious tone from companies, with limited visibility on a solid rebound in a persistently uncertain market environment (geopolitical situation, US politics, etc.), even if there are some signs of recovery and certain sectors remain very well positioned (leisure, energy, defence). At th...
ALLIX WALLIX GROUP SA
NXI NEXITY SA CLASS A
DBG DERICHEBOURG SA
INF INFOTEL SA
UNIQA INSURANCE GROUP AG
ASY ASSYSTEM SA
BLC BASTIDE LE CONFORT MEDICAL SA
KCO KLOECKNER & CO SE
ALTR ALTRI SGPS SA
SWP SWORD GROUP SE
CGM CEGEDIM SA
AUB AUBAY SA
EKI EKINOPS SA
VLS VALNEVA SE
MRN MERSEN SA
FII LISI SA
LSS LECTRA SA
LNA LNA SANTE SA
JCQ JACQUET METALS SA
GOE GROUPE GORGE SA
CDA COMPAGNIE DES ALPES SA
ELG ELMOS SEMICONDUCTOR SE
ALCAR CARMAT SA
QDT QUADIENT SA
IMPN IMPLENIA AG
IDIP INSTITUT DE DEVELOPPEMENT INDUSTRIEL SCA
DEZ DEUTZ AG
COR CORTICEIRA AMORIM SGPS SA
TUB TUBACEX S.A.
HEIJM HEIJMANS N.V. CERT
PAL
RIEN PALFINGER AG
AMG RIETER HOLDING AG
EDR AMG ADVANCED METALLURGICAL GROUP N.V.
ALBFR EDREAMS ODIGEO SA
ZAG SIDETRADE SA
POST ZUMTOBEL GROUP AG
FACC OSTERREICHISCHE POST AG
AXS FACC AG
HBH ACCSYS TECHNOLOGIES
TRE HORNBACH HOLDING AG & CO. KGAA
SMCP TECNICAS REUNIDAS SA
BFSA SMCP SA
VOS BEFESA SA
CAF VOSSLOH AG
MEDCL CONSTRUCCIONES Y AUXILIAR DE FERROCARRILES S.A.
EAT MEDINCELL SA
WAVE AMREST HOLDINGS SE
GRE WAVESTONE SA
THEP GRENERGY RENOVABLES
ALCUR THERMADOR HOLDING SA
FQT ARCURE SA
CLA FREQUENTIS AG WIENER
S30 CLARANOVA SE
ALHGR SOLUTIONS 30 SE
NACON HOFFMANN GREEN CEMENT TECHNOLOGIES SA
DSC1 NACON SASU
KTA DUTCH STAR C SHAR
UPG KNAUS TABBERT
ALAFY UNIFIEDPOST GROUP
FORSE AFYREN
WAGA FORSEE POWER SA
EAPI WAGA ENERGY SA
ACAG EUROAPI
ARVEN AUSTRIACARD HOLDINGS AG
ORP ARVERNE GROUP SA
VIRI ORPEA
LOCAL VIRIDIEN
SOLOCAL GROUP
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.